Description

Molina Healthcare’s $1 Billion Marketplace Reset — Can It Clear The Path For A Stronger 2027?

Molina Healthcare’s second quarter 2026 results reflect mixed performance across its key business segments amid ongoing market and regulatory challenges. The company reported adjusted earnings per share (EPS) of $1.51 on premium revenue of $10.2 billion, yielding a consolidated medical cost ratio (MCR) of 92.2%, consistent with stable operating execution despite a difficult medical cost environment. Within segments, Medicaid delivered an MCR of 92.7%, aligning with expectations and stable medical cost trends projected at 5% for the full year. The Medicaid segment’s pretax margin improved modestly due in part to first-half outperformance, resulting in a slight upward revision of full-year adjusted EPS guidance for Medicaid to $5.75. Management continues to view 2026 as a trough year for Medicaid margins, anticipating stabilization and eventual correction via future rate increases. Medicare outperformed expectations, particularly in the dual-eligible (duals) population, with an MCR of 90.7% and improved cost trends in certain categories.